Medical News

RSS

IsoRay to sell $2.25 million in common stock

IsoRay Inc. has entered a securities purchase agreement with an investor to sell $2.25 million in common stock with the potential of $2,075,000 additional funding through two subsequent short term warrant tranches of 90 days and 180 days assuming an average exercise price of $1.40 and that all Series A and B warrants are exercised. Additional funding will occur if Series C or D warrants are exercised.

22 Nov 2010

Agilent's GeneSpring Bioinformatics Solution integrated with GeneGo's MetaCore

GeneGo, Inc., a leading provider of databases, software and services in systems biology and chemistry, and Agilent Technologies, Inc., the world's premier measurement company and a technology leader in chemical analysis, life sciences, electronics and communications, announced today that they have integrated Agilent's GeneSpring Bioinformatics Solution with MetaCore.

22 Nov 2010

BioNeutral signs 'Stand Still' agreement with DFB

BioNeutral Group, Inc., a specialty technology-based life science company, today announced it has signed a "Stand Still" agreement with a leading pharmaceutical company, DFB Pharmaceuticals, Inc. (DFB).

From Evident Corporation - Life Sciences 22 Nov 2010

Bacterin secures $8 million financing from WTI

Bacterin International Holdings, Inc., a creator and developer of revolutionary bone graft material and anti-infective coatings for medical applications, today announced that it has secured an asset based lending facility of up to $8.0 million from Western Technology Investment, and has received approximately $980,000 through the exercise of warrants for a total of approximately $9 million potentially available for the Company's use.

22 Nov 2010

Spectral enters distribution agreement with Toray to market TORAYMYXIN in Canada

Spectral Diagnostics Inc., today announced that it has signed a long-term, exclusive distribution agreement with Toray Industries, Inc. and Toray Medical Co., Ltd. of Japan (collectively "Toray") to market and sell Toraymyxin™ in Canada. Toraymyxin™ is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream. This product and Spectral's EAA™ diagnostic, which measures endotoxin and identifies patients for treatment, are already approved for sale by Health Canada.

22 Nov 2010

Parental divorce during childhood linked to stroke in adulthood

Children who experience a parental divorce are over twice as likely to suffer a stroke at some point in their lives, according to new research presented in New Orleans at The Gerontological Society of America's (GSA) 63rd Annual Scientific Meeting.

22 Nov 2010

First Edition: November 22, 2010

Today's headlines offer a range of health policy stories, including more reports on deficit reduction issues, the continuing politics swirling around the health law repeal effort and employers' soaring health care costs.

22 Nov 2010

DaVita announces meal planning tool for dialysis patients

DaVita Inc., a leading provider of kidney care services for those diagnosed with end stage renal disease (ESRD) and chronic kidney disease (CKD), offers patients with very restricted diets an easy to use meal planning tool and recipes for their favorite Thanksgiving dinners at DaVita.com.

22 Nov 2010

Medisafe 1 presents barcoded syringe locking device at Medica 2010 Conference

Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company's exhibition of its barcoded syringe locking device generated overwhelming interest at the annual Medica 2010 Conference in Dusseldorf Germany, held November 16-19.

22 Nov 2010

Interim results from H.P. Acthar Gel study in patients with advanced diabetic nephropathy

On November 20 at the American Society of Nephrology 43rd Annual Meeting, interim results presented from an ongoing, randomized prospective study conducted independently by James A. Tumlin, MD, at the University of Tennessee College of Medicine Chattanooga indicated that 9 of 15 patients (60%) with advanced diabetic nephropathy who are currently enrolled in the study and have completed or are still undergoing a six month course of treatment with H.P. Acthar ® Gel have exhibited a clinically significant decrease in proteinuria and achieved stabilized renal function.

22 Nov 2010

NASDAQ issues second letter to A.P. Pharma

A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that, on November 17, 2010, it received a second letter from the Listing Qualifications Staff of The NASDAQ Stock Market (NASDAQ) indicating that it has not regained compliance with Listing Rule 5550(a)(2), which requires the closing bid price of the Company's common stock to be $1.00 or more.

22 Nov 2010

Toshiba receives top ratings on IMV ServiceTrak's 2010 MRI system service report

As healthcare organizations continue to look for the best value in imaging and customer service, Toshiba America Medical Systems, Inc.'s Service organization continues to deliver on the company's dedication to top-tier service and customer satisfaction. In the 2010 IMV ServiceTrak™ ratings report on MRI system service, Toshiba received more number one ratings than any other manufacturer in the categories of Service Performance, Phone Support Performance and Remote Service.

22 Nov 2010

Acthar Gel may be a viable treatment option for resistant nephrotic syndrome

On November 20 at the American Society of Nephrology 43rd Annual Meeting, Columbia University Assistant Professor of Clinical Medicine Andrew Bomback, MD, presented results from a patient case series assessing the potential therapeutic value of H.P. Acthar Gel (repository corticotropin injection) as a treatment for patients with nephrotic syndrome, a kidney disorder characterized by excessive loss of urinary protein.

22 Nov 2010

ContextVision launches GOPView CT image enhancement software on standard CPU platform

ContextVision, the software imaging partner for the most recognized medical imaging manufacturers worldwide, today announced GOPView® CT, the company's CT image enhancement software, on a standard CPU platform. This standalone cost-effective CPU-based solution enables OEMs to leverage advanced imaging technology for low dose CT imaging.

22 Nov 2010

CDS introduces new genre to online learning content

The College of Direct Support (CDS), an internet-based curriculum for Direct Support Professionals (DSPs) and managed in partnership by Elsevier/MC Strategies and the University of Minnesota's Research and Training Center, has introduced its latest offering in the form of a new genre of its online learning content.

22 Nov 2010

Variation at gene locus associated with greater reproductive success

Since 1871, when Charles Darwin wrote The Descent of Man, it has been widely accepted that "Variability is the necessary basis for the action of selection." Variability is associated with the ability to adapt, which is clearly beneficial at a species level. But there is increasing evidence that genetic variability may also give rise to advantages at the level of the individual.

22 Nov 2010

WHO's guidance to governments on ways to finance health care

Governments worldwide are struggling to pay for health care. As populations get older, as more people suffer chronic diseases, and as new and more expensive treatments appear, health costs soar.

22 Nov 2010

Stealth Peptides introduces Bendavia clinical candidate at AHA Scientific Sessions

Stealth Peptides, a privately held biopharmaceutical company developing innovative mitochondrial therapies for diseases with significant unmet medical needs, introduced its lead clinical candidate, Bendavia, a novel compound that targets the mitochondrion, at the 2010 American Heart Association's (AHA) Scientific Sessions, Resuscitation Science Symposium.

22 Nov 2010

Global biotechnology company selects ReadSoft's SAP-certified invoice processing solution

A leading international biotechnology company has selected ReadSoft's SAP-certified invoice processing solution to process paper and electronic invoices in North America. After implementing SAP more than a year ago, the company now wanted to automate its invoice processing. ReadSoft was chosen because of its proven expertise from similar implementations in SAP environments. The deal was signed during the third quarter of 2010.

22 Nov 2010

SIS perioperative modular EHR achieves ONC-ATCB meaningful use certification

Surgical Information Systems (SIS), a leader in perioperative information systems, announced today that SIS Version 5 has been certified to meet 2011/2012 Stage 1 meaningful use measures as a modular Electronic Health Record (EHR). Certification was conducted by the Drummond Group, an Office of the National Coordinator for Health Information Technology Authorized Testing and Certification Body (ONC-ATCB).

22 Nov 2010